News
06-20-2011, 12:10 AM
Researchers at Fred Hutchinson Cancer Research Center have demonstrated in mice that the performance of a novel biomarker-development pipeline using targeted mass spectrometry is robust enough to support the use of an analogous approach in humans.
More... (http://www.news-medical.net/news/20110620/Novel-biomarker-development-pipeline-approach-for-human-diseases.aspx)
More... (http://www.news-medical.net/news/20110620/Novel-biomarker-development-pipeline-approach-for-human-diseases.aspx)